Methotrexate mechanism of action:
Now, the correct answer should be the one that states inhibition of dihydrofolate reductase. Let me check the options. The user didn't provide them, but common distractors might include other enzymes like thymidylate synthase (which 5-FU inhibits), or maybe DNA gyrase (like fluoroquinolones), or even topoisomerase.
For each wrong option, I need to explain why they're incorrect. For example, if an option says "inhibits thymidylate synthase," that's wrong because that's 5-FU's mechanism. Another wrong option might be "inhibits DNA gyrase," which is relevant for bacterial DNA replication, not methotrexate.
The clinical pearl should highlight that methotrexate is used in rheumatoid arthritis and cancer, and its mechanism targets folate metabolism. Also, it's a folate antagonist, so leucovorin rescue is used to mitigate toxicity.
I need to make sure each section is concise, using bold for key terms. Let me structure the explanation step by step, ensuring all sections are covered without exceeding the character limit. Check for any medical inaccuracies, like confusing methotrexate with other drugs. Also, mention that it's a competitive inhibitor of DHFR, leading to impaired nucleotide synthesis. That's the core concept.
Wait, the options weren't provided, but the correct answer is likely option C or D. The user's correct answer is missing the letter and text. Assuming the correct answer is about DHFR inhibition. Need to make sure the explanation is clear even without the exact options. Maybe the options are about different enzymes, so the explanation should address common alternatives.
**Core Concept**
Methotrexate is a folate antagonist that inhibits **dihydrofolate reductase (DHFR)**, an enzyme critical for converting dihydrofolate to tetrahydrofolate. Tetrahydrofolate is essential for the synthesis of purines and thymidylate, which are required for DNA replication in rapidly dividing cells.
**Why the Correct Answer is Right**
Methotrexate competitively inhibits DHFR, preventing the regeneration of tetrahydrofolate from dihydrofolate. This blocks the production of purines and thymidylate, leading to DNA synthesis inhibition. It is particularly effective in malignancies (e.g., leukemia) and autoimmune diseases (e.g., rheumatoid arthritis) by targeting proliferating cells. High-dose methotrexate requires leucovorin rescue to provide exogenous tetrahydrofolate and prevent toxicity in normal cells.
**Why Each Wrong Option is Incorrect**
**Option A:** If the option states “inhibits thymidylate synthase,” it is incorrect because this mechanism belongs to 5-fluorouracil